The Valley Desk

Clinical trial reportCancerPublished

A phase 1 dose-escalation study of LY3295668 erbumine as monotherapy and in combination with topotecan and cyclophosphamide in children with relapsed/refractory neuroblastoma

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Cancer
Published
Subject terms
Humans; Neuroblastoma; Neoplasm Recurrence, Local; Cyclophosphamide; Topotecan; Piperidines; Pyrazoles; Antineoplastic Combined Chemotherapy Protocols; Treatment Outcome; Maximum Tolerated Dose; Dose-Response Relationship, Drug; Adolescent
PubMed ID
39932800
Added to directory
Source checked

Report a correction or request removal